| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
SRA
|
Mus musculus
|
Sep 06, 2022
|
||||||
| GSM6534367 |
Cell line EO771, +doxy +miR200c, rep3
|
SRA |
|
1 | Tonya Brunetti | Sep 06, 2022 | |||
| GSM6542214 |
TAM Tumor Rep 1
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542215 |
TAM Tumor Rep 2
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542216 |
TAM Tumor Rep 3
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542217 |
MTM Tumor Rep 1
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542218 |
MTM Tumor Rep 2
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542219 |
MTM Tumor Rep 3
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542220 |
Monocyte Tumor Rep 1
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542221 |
Monocyte Tumor Rep 2
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542222 |
Monocyte Tumor Rep 3
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542223 |
DC1 Tumor Rep 1
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542224 |
DC1 Tumor Rep 2
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542225 |
DC2 Tumor Rep 1
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542226 |
DC2 Tumor Rep 2
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542227 |
IRF8FL TAM Tumor Rep 1
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542228 |
IRF8FL TAM Tumor Rep 2
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542229 |
CD11cCreIRF8FL TAM Tumor Rep 1
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542230 |
CD11cCreIRF8FL TAM Tumor Rep 2
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542231 |
CD8 T Cells from IRF8FLPyMT Tumor, scRNAseq
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 | |||
| GSM6542232 |
CD8 T Cells from MafBCreIRF8FLPyMT Tumor, scRNAseq
|
SRA |
|
1 | Fengshen Kuo | Sep 06, 2022 |
